Cargando…
Acute, High Dose Metformin Therapy at Reperfusion Decreases Infarct Size in the High-Risk Aging Heart
Elderly patients (age > 75) sustain larger infarcts with greater mortality from ST elevation myocardial infarcts (STEMI) despite successful reperfusion treatment. Elderly age remains an independent risk despite correction for clinical and angiographic variables. The elderly represent a high-risk...
Autores principales: | Bates, Lauryn, Krause-Hauch, Meredith, Wang, Hao, Fatmi, Mohammad Kasim, Li, Zehui, Chen, Qun, Ren, Di, Li, Ji, Lesnefsky, Edward J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529738/ https://www.ncbi.nlm.nih.gov/pubmed/37196121 http://dx.doi.org/10.14336/AD.2023.0205 |
Ejemplares similares
-
The Interaction of mTOR and Nrf2 in Neurogenesis and Its Implication in Neurodegenerative Diseases
por: Zoungrana, Linda Ines, et al.
Publicado: (2022) -
Sestrin2 Mediates Metformin Rescued the Age-Related Cardiac Dysfunctions of Cardiorenal Syndrome Type 3
por: Iglesias, Migdalia, et al.
Publicado: (2023) -
Cardiomyocyte Pdk4 response is associated with metabolic maladaptation in aging
por: Fatmi, Mohammad Kasim, et al.
Publicado: (2023) -
Targeting on Nrf2/Sesn2 Signaling to Rescue Cardiac Dysfunction during High-Fat Diet-Induced Obesity
por: Krause-Hauch, Meredith, et al.
Publicado: (2022) -
Chronic metformin treatment decreases cardiac injury during ischemia-reperfusion by attenuating endoplasmic reticulum stress with improved mitochondrial function
por: Chen, Qun, et al.
Publicado: (2021)